Published in J Clin Pathol on September 01, 2004
A virtual microscopy system to scan, evaluate and archive biomarker enhanced cervical cytology slides. Cell Oncol (2010) 1.03
An improved axillary staging system using the OSNA assay does not modify the therapeutic management of breast cancer patients. Sci Rep (2014) 0.77
Ziehl-Neelsen sputum smear microscopy image database: a resource to facilitate automated bacilli detection for tuberculosis diagnosis. J Med Imaging (Bellingham) (2017) 0.75
Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med (2000) 4.67
Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group. Lancet (1999) 3.50
Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol (2000) 3.13
Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: a multicenter study. Cancer (2000) 2.29
Axillary sentinel lymph node examination in breast carcinoma. Arch Pathol Lab Med (1999) 2.05
Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer. Arch Surg (2001) 1.34
Sentinel node biopsy as a practical alternative to axillary lymph node dissection in breast cancer patients: an approach to its validity. Ann Oncol (2000) 1.34
Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. Eur J Cancer (2003) 1.31
Histopathological workup of sentinel lymph nodes: how much is enough? J Clin Pathol (1999) 1.25
Sentinel lymph nodes and breast carcinoma: which micrometastases are clinically significant? Am J Surg Pathol (2003) 1.22
Classification of isolated tumor cells: clarification of the 6th edition of the American Joint Committee on Cancer Staging Manual. Cancer (2003) 1.21
Sentinel node investigation in breast cancer: detailed analysis of the yield from step sectioning and immunohistochemistry. J Clin Pathol (2001) 1.16
Complete sectioning of axillary sentinel nodes in patients with breast cancer. Analysis of two different step sectioning and immunohistochemistry protocols in 246 patients. J Clin Pathol (2002) 1.11
Multiparameter flow cytometry as a tool for the detection of micrometastatic tumour cells in the sentinel lymph node procedure of patients with breast cancer. J Clin Pathol (2002) 0.95
Sentinel lymph node mapping and biopsy for breast cancer: a review of the literature relative to 4791 procedures. Tumori (2000) 0.94
ADASP recommendations for processing and reporting of lymph node specimens submitted for evaluation of metastatic disease. Virchows Arch (2001) 0.93
Micro-metastases in axillary lymph nodes: an increasing classification and treatment dilemma in breast cancer due to the introduction of the sentinel lymph node procedure. Breast Cancer Res Treat (2001) 0.90
Occult metastases in sentinel nodes of 200 patients with operable breast cancer. Ann Surg Oncol (2001) 0.86
Evaluation of axillary sentinel lymph node biopsy by immunohistochemistry and multilevel sectioning in patients with breast carcinoma. Arch Pathol Lab Med (2000) 0.86
Stage migration in breast cancer: surgical decisions concerning isolated tumour cells and micro-metastases in the sentinel lymph node. Eur J Surg Oncol (2003) 0.84
Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma. J Exp Clin Cancer Res (2000) 0.80
Re: Chu et al "Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?". Ann Surg (2000) 0.80
Automated analysis of multiple sections for the detection of occult cells in lymph nodes. Clin Cancer Res (2003) 0.78
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet (2009) 7.30
Heterogeneity in telomere length of human chromosomes. Hum Mol Genet (1996) 6.55
Telomeres in the mouse have large inter-chromosomal variations in the number of T2AG3 repeats. Proc Natl Acad Sci U S A (1997) 4.88
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst (2010) 4.54
Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. J Natl Cancer Inst (2001) 4.27
Efficacy of 'radioguided occult lesion localisation' (ROLL) versus 'wire-guided localisation' (WGL) in breast conserving surgery for non-palpable breast cancer: a randomised controlled multicentre trial. Breast Cancer Res Treat (2012) 3.99
Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer. J Pathol (2001) 3.94
Risk factors for anastomotic failure after total mesorectal excision of rectal cancer. Br J Surg (2005) 3.57
Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva. J Clin Oncol (2000) 3.20
Photobleaching kinetics of fluorescein in quantitative fluorescence microscopy. Biophys J (1995) 3.08
Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1). J Pathol (2005) 2.70
Array-CGH detection of micro rearrangements in mentally retarded individuals: clinical significance of imbalances present both in affected children and normal parents. J Med Genet (2005) 2.60
Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent. Int J Cancer (1993) 2.60
Doxorubicin gradients in human breast cancer. Clin Cancer Res (1999) 2.36
Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns. J Pathol (2001) 2.33
Influence of the triplet excited state on the photobleaching kinetics of fluorescein in microscopy. Biophys J (1996) 2.11
Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer. J Clin Pathol (2005) 2.10
Ultra-sensitive FISH using peroxidase-mediated deposition of biotin- or fluorochrome tyramides. Hum Mol Genet (1995) 2.07
Radioactive seed localization for non-palpable breast cancer. Br J Surg (2013) 2.07
Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations. Gynecol Oncol (2000) 2.04
Linear 2' O-Methyl RNA probes for the visualization of RNA in living cells. Nucleic Acids Res (2001) 2.03
Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg (1998) 2.02
Relationships between vascularization and proliferation in invasive breast cancer. J Pathol (1999) 1.90
Reliability of intraoperative frozen section and imprint cytological investigation of sentinel lymph nodes in breast cancer. Histopathology (1999) 1.84
Activated cytotoxic T cells as prognostic marker in Hodgkin's disease. Blood (1997) 1.82
Giant colonic diverticula. Review of diagnostic and therapeutic options. Dig Surg (2003) 1.82
Sarcomatoid carcinoma of the urinary bladder. Clinicopathologic analysis of 18 cases with immunohistochemical and electron microscopic findings. Am J Surg Pathol (1994) 1.76
[The sentinel node procedure: standard intervention for surgical treatment of breast cancer]. Ned Tijdschr Geneeskd (1998) 1.76
Heterogeneity and reproducibility of microvessel counts in breast cancer. Lab Invest (1995) 1.75
Fluorochrome-labeled tyramides: use in immunocytochemistry and fluorescence in situ hybridization. J Histochem Cytochem (1997) 1.71
Up-converting phosphor reporters for nucleic acid microarrays. Nat Biotechnol (2001) 1.65
Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops. J Pathol (1998) 1.62
The implementation of the sentinel node biopsy as a routine procedure for patients with breast cancer. Surgery (2000) 1.61
Expression of differentiation and proliferation related proteins in epithelium of prophylactically removed ovaries from women with a hereditary female adnexal cancer predisposition. Histopathology (2003) 1.59
Interlaboratory reproducibility of semiautomated cell cycle analysis of flow cytometry DNA-histograms obtained from fresh material of 1,295 breast cancer cases. Hum Pathol (1996) 1.58
Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis. J Pathol (1998) 1.58
The TWIST1 oncogene is a direct target of hypoxia-inducible factor-2alpha. Oncogene (2007) 1.57
Mutational analysis of fibrillarin and its mobility in living human cells. J Cell Biol (2000) 1.57
Comparative genomic hybridisation. Mol Pathol (1999) 1.56
Progression from colorectal adenoma to carcinoma is associated with non-random chromosomal gains as detected by comparative genomic hybridisation. J Clin Pathol (1998) 1.54
Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers. Br J Cancer (2005) 1.54
Clinical and genetic evaluation of thirty ovarian cancer families. Am J Obstet Gynecol (1998) 1.49
Extended neoadjuvant chemotherapy in locally advanced breast cancer combined with GM-CSF: effect on tumour-draining lymph node dendritic cells. Eur J Cancer (2003) 1.48
Hypoxia-inducible factor-1alpha is associated with angiogenesis, and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer. Histopathology (2005) 1.47
The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial. Ann Oncol (2012) 1.46
In-transit lymph node metastases in breast cancer: a possible source of local recurrence after Sentinel Node procedure. J Clin Pathol (2008) 1.42
Impactitis: new cures for an old disease. J Clin Pathol (2001) 1.42
Histopathology of fibroadenoma of the breast. Am J Clin Pathol (2001) 1.41
High 1-year complication rate after anterior resection for rectal cancer. J Gastrointest Surg (2013) 1.41
Systematic review and meta-analysis of the volume-outcome relationship in pancreatic surgery. Br J Surg (2011) 1.40
DNA profiling of primary serous ovarian and fallopian tube carcinomas with array comparative genomic hybridization and multiplex ligation-dependent probe amplification. J Pathol (2007) 1.40
Whipple's disease: easily diagnosed, if considered. Neth J Med (2008) 1.39
[Oesophageal endoscopic ultrasound with fine-needle aspiration biopsy in the staging of non-small-cell lung carcinoma; results from 43 patients]. Ned Tijdschr Geneeskd (2006) 1.39
Prognostic significance of the tumor-stroma ratio: validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854). Breast Cancer Res Treat (2013) 1.39
Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variant. J Med Genet (2004) 1.39
Methods for visualizing RNA processing and transport pathways in living cells. Histochem Cell Biol (2001) 1.38
Quality control methods for data entry in pathology using a computerized data management system based on an extended data dictionary. Hum Pathol (1992) 1.38
Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer. Arch Surg (2001) 1.34
Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast. Mol Pathol (2000) 1.34
Expression of HLA-DR on T lymphocytes following renal transplantation, and association with graft-rejection episodes and cytomegalovirus infection. Transplantation (1984) 1.32
Primary extranodal non-Hodgkin lymphoma of the oral cavity. An analysis of 34 cases. Eur J Cancer B Oral Oncol (1994) 1.31
Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach. J Clin Pathol (1999) 1.28
Infrared up-converting phosphors for bioassays. IEE Proc Nanobiotechnol (2005) 1.27
Functional lymphatic anatomy for sentinel node biopsy in breast cancer: echoes from the past and the periareolar blue method. Ann Surg (2000) 1.27
A homozygous deletion of a normal variation locus in a patient with hearing loss from non-consanguineous parents. J Med Genet (2009) 1.26
T lymphocyte characteristics in bone marrow-transplanted patients. II. Analysis with monoclonal antibodies. J Immunol (1981) 1.26
Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two different lines of genetic evolution. J Pathol (2001) 1.26
Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer. J Nucl Med (1997) 1.25
The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma. Cancer (2001) 1.25
Histopathological workup of sentinel lymph nodes: how much is enough? J Clin Pathol (1999) 1.25
Centralization of esophageal cancer surgery: does it improve clinical outcome? Ann Surg Oncol (2009) 1.25
Lack of lymphangiogenesis during breast carcinogenesis. J Clin Pathol (2004) 1.25
Distinction between hereditary and sporadic breast cancer on the basis of clinicopathological data. J Clin Pathol (2006) 1.24
BHRF1, the Epstein-Barr virus (EBV) homologue of the BCL-2 protooncogene, is transcribed in EBV-associated B-cell lymphomas and in reactive lymphocytes. Blood (1995) 1.24
Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancer. Br J Cancer (1998) 1.23
Multiple fluorescence in situ hybridization. Cytometry (1990) 1.22
Molecular imaging of breast cancer. Breast (2009) 1.22
Prognostic role of thymidylate synthase, thymidine phosphorylase/platelet-derived endothelial cell growth factor, and proliferation markers in colorectal cancer. Clin Cancer Res (2000) 1.21
Ultrasound-guided laser-induced thermal therapy for small palpable invasive breast carcinomas: a feasibility study. Ann Surg Oncol (2009) 1.20
A systematic review and meta-analysis of the volume-outcome relationship in the surgical treatment of breast cancer. Are breast cancer patients better of with a high volume provider? Eur J Surg Oncol (2010) 1.19
Identification of genetic markers for prostatic cancer progression. Lab Invest (2000) 1.19
Comparative genomic hybridization of cancer of the gastroesophageal junction: deletion of 14Q31-32.1 discriminates between esophageal (Barrett's) and gastric cardia adenocarcinomas. Cancer Res (1999) 1.18
Importance of the first postoperative year in the prognosis of elderly colorectal cancer patients. Ann Surg Oncol (2011) 1.18
Volume and outcome in colorectal cancer surgery. Eur J Surg Oncol (2010) 1.17
Mass spectrometry proteomic diagnosis: enacting the double cross-validatory paradigm. J Comput Biol (2006) 1.17
Interplay between VHL/HIF1alpha and Wnt/beta-catenin pathways during colorectal tumorigenesis. Oncogene (2006) 1.17
ULS: a versatile method of labeling nucleic acids for FISH based on a monofunctional reaction of cisplatin derivatives with guanine moieties. Cytogenet Cell Genet (1999) 1.16
Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases. Am J Pathol (2000) 1.16
Sentinel node investigation in breast cancer: detailed analysis of the yield from step sectioning and immunohistochemistry. J Clin Pathol (2001) 1.16
Quality of life after transanal endoscopic microsurgery and total mesorectal excision in early rectal cancer. Colorectal Dis (2007) 1.16
Current technologies for HER2 testing in breast cancer. Crit Rev Oncol Hematol (2011) 1.14
Single nucleotide polymorphism array analysis of chromosomal instability patterns discriminates rectal adenomas from carcinomas. J Pathol (2007) 1.13
Prognostic relevance of P-glycoprotein expression in breast cancer. Ann Oncol (1995) 1.13
Analysis of antifading reagents for fluorescence microscopy. Cytometry (1995) 1.13
Methylation is less abundant in BRCA1-associated compared with sporadic breast cancer. Ann Oncol (2008) 1.12
Diagnosis of breast lesions: fine-needle aspiration cytology or core needle biopsy? A review. J Clin Pathol (2011) 1.12
Impact of centralization of pancreatic cancer surgery on resection rates and survival. Br J Surg (2014) 1.11
Molecular cytogenetic analysis of prostatic adenocarcinomas from screening studies : early cancers may contain aggressive genetic features. Am J Pathol (2001) 1.11
Hot spot microvessel density and the mitotic activity index are strong additional prognostic indicators in invasive breast cancer. Histopathology (2000) 1.10